US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Astellas Pharma, Inc.

15.14

-1.1870-7.27%

Volume:525.00

Turnover:8.20K

Market Cap:28.18B

PE:203.60

High:17.14

Open:17.14

Low:15.14

Close:16.33

52wk High:17.14

52wk Low:8.41

Shares:1.86B

Float Shares:1.73B

Volume Ratio:0.27

T/O Rate:0.00%

Dividend:0.51

Dividend Rate:3.40%

EPS(TTM):0.0744

EPS(LYR):0.0628

ROE:19.82%

ROA:7.38%

PB:2.45

PE(LYR):240.89

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Astellas Pharma, Inc.

Exchange:

PINK LIMITED

Establishment Date:

1923

Employees:

13643

Office Location:

2-5-1, Nihonbashi-Honcho,Chuo,Tokyo,Japan

Website:

http://www.astellas.com/en/index.html

Zip Code:

103-8411

Phone:

Fax:

- -

Introduction:

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALPMF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALPMF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":15.138,"timestamp":1770930000000,"preClose":16.325,"halted":0,"volume":525,"delay":15,"changeRate":-0.07271056661562018,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"Closed","change":-1.187,"latestTime":"02-12 16:00:00 EST Delay","open":17.14,"high":17.14,"low":15.138,"amount":8197.7,"amplitude":0.122634,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770973200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":16.325,"volumeRatio":0.266038},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALPMF\",,,,,undefined,":{"symbol":"ALPMF","floatShares":1731101601,"roa":"7.38%","roe":"19.82%","lyrEps":0.062841,"volumeRatio":0.266038,"shares":1861787075,"dividePrice":0.5141,"high":17.14,"amplitude":0.122634,"preClose":16.325,"low":15.138,"week52Low":8.405,"pbRate":"2.45","psRate":"2.09","week52High":17.14,"institutionHeld":0,"latestPrice":15.138,"eps":0.074352,"divideRate":0.033961,"volume":525,"delay":15,"ttmEps":0.074352,"open":17.14,"prevYearClose":13.17,"prevWeekClose":14.9,"prevMonthClose":13.9383,"prevQuarterClose":13.17,"fiveDayClose":14.9,"twentyDayClose":13.35,"sixtyDayClose":12.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALPMF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-04-25","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1698811200000,"reportTimeType":"","actualEps":null},{"date":"2023-09-28","symbol":"ALPMF","amount":35,"announcedDate":"2023-07-19","type":"dividend","market":"US","newRecordDate":"2023-09-30","defaultRemindTime":1695907800000,"name":"Astellas Pharma, Inc.","recordDate":"2023-12-01","payableDate":"2023-09-30","currency":"JPY","dateTimestamp":1695873600000,"payDate":"2023-12-01"},{"market":"US","date":"2023-08-01","symbol":"ALPMF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1690862400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-27","recordDate":"2019-03-31","paymentDate":"2019-06-18","value":19,"currency":"JPY"},{"executeDate":"2019-09-27","recordDate":"2019-09-30","paymentDate":"2019-12-03","value":20,"currency":"JPY"},{"executeDate":"2020-03-30","recordDate":"2020-03-31","paymentDate":"2020-06-19","value":20,"currency":"JPY"},{"executeDate":"2020-09-29","recordDate":"2020-09-30","paymentDate":"2020-12-01","value":21,"currency":"JPY"},{"executeDate":"2021-03-30","recordDate":"2021-03-31","paymentDate":"2021-06-01","value":21,"currency":"JPY"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALPMF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":874641,"yearFounded":1923,"employeeNum":13643,"address":"2-5-1, Nihonbashi-Honcho,Chuo,Tokyo,Japan","zipCode":"103-8411","officePhone":"81 3 3244 3000"},"stockCompanyDetail":{"websiteUrl":"http://www.astellas.com/en/index.html","stockEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0549},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.0147},{"period":"1year","weight":-0.1856},{"period":"ytd","weight":0.0926}],"description":"Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex's GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"Astellas Pharma, Inc.","nameEN":"Astellas Pharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALPMF\",market:\"US\",,,undefined,":null}}